The results were notable: participants receiving the highest dose (12 mg weekly) achieved a mean body weight reduction of approximately 24% from baseline
2014 Dec 30;9(12):e115942
Monitoring and Safety Guidance for GLP-1 Users in the UK For patients appropriately prescribed GLP-1 receptor agonists, routine thyroid cancer screening is not recommended according to the product information for these medications
Many patients also explore medical weight loss when weight gain begins affecting energy levels, sleep, or overall quality of life
Thats because Wegovy (the brand name for the drug semaglutide thats been FDA-approved for weight management) is a peptide a small protein thats a synthetic version of the hormone GLP-1
These medications were originally developed to manage type 2 diabetes and, later, obesity, but a growing body of research suggests they also have broad anti-inflammatory and immunomodulatory effects across multiple organ systems